enVVeno Medical Corp APIC, Share-based Payment Arrangement, Increase for Cost Recognition
enVVeno Medical Corp (NVNO) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $397.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-07-30
- enVVeno Medical Corp apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $397.00K, a 72.51% decline year-over-year.
- enVVeno Medical Corp apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $467.00K, a 28.26% decline year-over-year.
- enVVeno Medical Corp apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $637.00K, a 37.43% decline year-over-year.
- enVVeno Medical Corp apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $688.00K, a 31.41% decline year-over-year.
- enVVeno Medical Corp apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $3.42M, a 17.41% decline from fiscal 2024.
- enVVeno Medical Corp apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $4.14M, a 20.30% decline from fiscal 2023.
- enVVeno Medical Corp apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $5.20M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $397.00K 10-Q · filed 2026-07-30 | $864.00K 10-Q · filed 2026-07-30 | $1.50M derived: sum of 3 quarters · filed 2026-07-30 | $2.19M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $467.00K 10-Q · filed 2026-05-06 | $1.10M derived: sum of 2 quarters · filed 2026-05-06 | $1.79M derived: sum of 3 quarters · filed 2026-05-06 | $3.24M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $637.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.32M derived: sum of 2 quarters · filed 2026-03-26 | $2.77M derived: sum of 3 quarters · filed 2026-07-30 | $3.42M 10-K · filed 2026-03-26 |
| 2025-09-30 | $688.00K 10-Q · filed 2025-10-30 | $2.13M derived: sum of 2 quarters · filed 2026-07-30 | $2.78M 10-Q · filed 2025-10-30 | $3.80M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $1.44M 10-Q · filed 2026-07-30 | $2.10M 10-Q · filed 2026-07-30 | $3.11M derived: sum of 3 quarters · filed 2026-07-30 | $4.12M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $651.00K 10-Q · filed 2026-05-06 | $1.67M derived: sum of 2 quarters · filed 2026-05-06 | $2.67M derived: sum of 3 quarters · filed 2026-05-06 | $3.68M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $2.02M derived: sum of 2 quarters · filed 2026-03-26 | $3.03M derived: sum of 3 quarters · filed 2026-03-26 | $4.14M 10-K · filed 2026-03-26 |
| 2024-09-30 | $1.00M 10-Q · filed 2025-10-30 | $2.01M derived: sum of 2 quarters · filed 2025-10-30 | $3.12M 10-Q · filed 2025-10-30 | $4.27M derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | $1.00M 10-Q · filed 2025-07-31 | $2.12M 10-Q · filed 2025-07-31 | $3.26M derived: sum of 3 quarters · filed 2025-07-31 | $4.37M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $1.11M 10-Q · filed 2025-04-30 | $2.26M derived: sum of 2 quarters · filed 2025-04-30 | $3.36M derived: sum of 3 quarters · filed 2025-04-30 | |
| 2023-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $2.25M derived: sum of 2 quarters · filed 2025-02-28 | $5.20M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $1.10M 10-Q · filed 2024-10-31 | $4.05M 10-Q · filed 2024-10-31 | ||
| 2022-06-30 | $2.24M 10-Q · filed 2022-08-03 | $4.48M derived: sum of 2 quarters · filed 2022-08-03 | ||
| 2022-03-31 | $2.24M 10-Q · filed 2022-08-03 | |||
| 2021-06-30 | $203.00K 10-Q · filed 2022-08-03 | $310.00K derived: sum of 2 quarters · filed 2022-08-03 | ||
| 2021-03-31 | $107.00K 10-Q · filed 2022-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |